An emerging clone, klebsiellapneumoniae carbapenemase 2-producing K. pneumoniae sequence type 16, associated with high mortality rates in a CC258-endemic setting

Clinical Infectious Diseases

Volumn 71, Issue 7, 2020, Pages E141-E150

  Andrey, Diego O ^a,b   Dantas, Priscila Pereira ^c   Martins, Willames B S ^a,c   de Carvalho, Fabíola Marques ^d   Almeida, Luiz Gonzaga Paula ^d   Sands, Kirsty ^a   Portal, Edward ^a   Sauser, Julien ^b   Cayô, Rodrigo ^c   Nicolas, Marisa F ^d   Vasconcelos, Ana Tereza R ^d   Medeiros, Eduardo A ^c   Walsh, Timothy R ^a   Gales, Ana C ^c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d LABORATÓRIO NACIONAL DE COMPUTAÇÃO CIENTÍFICA   (Brazil)

Author keywords

Bloodstream infections; Carbapenem resistant Enterobacteriaceae; CC258; Klebsiella pneumoniae; KPC

Indexed keywords

AMIKACIN; CARBAPENEMASE; MEROPENEM; POLYMYXIN B; YERSINIABACTIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ADULT; AGED; ALL CAUSE MORTALITY; AMINOGLYCOSIDE RESISTANCE; ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL CAPSULE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; CHARLSON COMORBIDITY INDEX; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FATALITY; FEMALE; GALLERIA MELLONELLA; HEMATOLOGIC MALIGNANCY; HEPATOBILIARY DISEASE; HUMAN; IN VITRO STUDY; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE; LARVA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MORTALITY RATE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PLASMID; POLYMYXIN RESISTANCE; PRIORITY JOURNAL; REPLICON; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; SURVIVAL ANALYSIS; TYPE IV SECRETION SYSTEM; WHOLE GENOME SEQUENCING; YOUNG ADULT; BRAZIL; CELL CLONE; GENETICS; KLEBSIELLA INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BRAZIL; CLONE CELLS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MULTILOCUS SEQUENCE TYPING; RETROSPECTIVE STUDIES;

EID: 85081657643     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciz1095     Document Type: Article

References (38)

1. Centers for Diseases Control and Prevention. Carbapenem-resistant Enterobacteriaceae (CRE). Available at: https://www.cdc.gov/hai/organisms/cre/ index.html. Accessed 18 January 2019.
2. World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Available at: http://www.who. int/infection-prevention/publications/guidelines-cre/en/. Accessed 18 January 2019.
3. Public Health England. Carbapenem resistance: guidance, data and analysis. Available at: https://www.gov.uk/government/collections/carbapenemresistance- guidance-data-and-analysis. Accessed 18 January 2019.
4. Rodriguez-Bano J, Gutierrez-Gutierrez B, Machuca I, Pascual A. Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev 2018; 31.
5. Antochevis LC, Magagnin CM, Nunes AG, et al. KPC-producing Klebsiella pneumoniae bloodstream isolates from Brazilian hospitals: what (still) remains active? J Glob Antimicrob Resist 2018; 15:173-7.
6. Raut S, Adhikari B. Ceftazidime-avibactam in ceftazidime-resistant infections. Lancet Infect Dis 2016; 16:997.
7. Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13:785-96.
8. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9:228-36.
9. Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA, Kreiswirth BN. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol 2014; 22:686-96.
10. Chen L, Mathema B, Pitout JD, DeLeo FR, Kreiswirth BN. Epidemic Klebsiella pneumoniae ST258 is a hybrid strain. MBio 2014; 5:e01355-14.
11. Zhang R, Liu L, Zhou H, et al. Nationwide surveillance of clinical carbapenemresistant Enterobacteriaceae (CRE) strains in China. EBioMedicine 2017; 19:98-106.
12. Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 2018; 18:37-46.
13. Bartolleti F, Seco BM, Capuzzo Dos Santos C, et al. Polymyxin B resistance in carbapenem-resistant Klebsiella pneumoniae, Sao Paulo, Brazil. Emerg Infect Dis 2016; 22:1849-51.
14. Andrade LN, Curiao T, Ferreira JC, et al. Dissemination of blaKPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil. Antimicrob Agents Chemother 2011; 55:3579-83.
15. Braun G, Cayo R, Matos AP, de Mello Fonseca J, Gales AC. Temporal evolution of polymyxin B-resistant Klebsiella pneumoniae clones recovered from blood cultures in a teaching hospital during a 7-year period. Int J Antimicrob Agents 2018; 51:522-7.
16. Pereira PS, de Araujo CF, Seki LM, Zahner V, Carvalho-Assef AP, Asensi MD. Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340). J Antimicrob Chemother 2013; 68:312-6.
17. Seki LM, Pereira PS, de Souza Mda P, et al. Molecular epidemiology of KPC-2- producing Klebsiella pneumoniae isolates in Brazil: the predominance of sequence type 437. Diagn Microbiol Infect Dis 2011; 70:274-7.
18. Andrade LN, Novais A, Stegani LMM, et al. Virulence genes, capsular and plasmid types of multidrug-resistant CTX-M(-2, -8, -15) and KPC-2-producing Klebsiella pneumoniae isolates from four major hospitals in Brazil. Diagn Microbiol Infect Dis 2018; 91:164-8.
19. European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints and dosing of antibiotics. Available at: http://www.eucast.org/clinical- breakpoints/. Accessed 22 September 2018.
20. Centers for Disease Control and Prevention. PulseNet standard protocol. Available at: https://www.cdc.gov/pulsenet/pdf/ecoli-shigella-salmonella-pfgeprotocol- 508c.pdf. Accessed 15 September 2017.
21. Bacterial Isolate Genome Sequence Database (BIGS). Available at: https://bigsdb. pasteur.fr/klebsiella/klebsiella.html. Accessed 22 September 2018.
22. Yang Q, Li M, Spiller OB, et al. Balancing mcr-1 expression and bacterial survival is a delicate equilibrium between essential cellular defence mechanisms. Nat Commun 2017; 8:2054.
23. Tumbarello M, Trecarichi EM, De Rosa FG, et al; ISGRI-SITA (Italian Study Group on Resistant Infections of the Societa Italiana Terapia Antinfettiva). Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 2015; 70:2133-43.
24. Falcone M, Russo A, Iacovelli A, et al. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin Microbiol Infect 2016; 22:444-50.
25. Gutierrez-Gutierrez B, Salamanca E, de Cueto M, et al; REIPI/ESGBIS/ INCREMENT Investigators. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis 2017; 17:726-34.
26. Hammerum AM, Hansen F, Olesen B, et al. Investigation of a possible outbreak of NDM-5-producing ST16 Klebsiella pneumoniae among patients in Denmark with no history of recent travel using whole-genome sequencing. J Glob Antimicrob Resist 2015; 3:219-21.
27. Perez-Vazquez M, Oteo J, Garcia-Cobos S, et al. Phylogeny, resistome and mobile genetic elements of emergent OXA-48 and OXA-245 Klebsiella pneumoniae clones circulating in Spain. J Antimicrob Chemother 2016; 71:887-96.
28. Moradigaravand D, Martin V, Peacock SJ, Parkhill J. Evolution and epidemiology of multidrug-resistant Klebsiella pneumoniae in the United Kingdom and Ireland. MBio 2017; 8.
29. Bathoorn E, Rossen JW, Lokate M, Friedrich AW, Hammerum AM. Isolation of an NDM-5-producing ST16 Klebsiella pneumoniae from a Dutch patient without travel history abroad, August 2015. Euro Surveill 2015; 20.
30. Avolio M, Vignaroli C, Crapis M, Camporese A. Co-production of NDM-1 and OXA-232 by ST16 Klebsiella pneumoniae, Italy, 2016. Future Microbiol 2017; 12: 1119-22.
31. Pereira PS, Borghi M, de Araujo CF, et al. Clonal dissemination of OXA-370- producing Klebsiella pneumoniae in Rio de Janeiro, Brazil. Antimicrob Agents Chemother 2015; 59:4453-6.
32. Guimaraes T, Nouer SA, Martins RCR, et al. Ceftazidime-avibactam as salvage therapy for infections caused by Enterobacteriales coresistant to carbapenems and polymyxins. Antimicrob Agents Chemother 2019; 63.
33. Lalaoui R, Bakour S, Livnat K, Assous MV, Diene SM, Rolain JM. Spread of Carbapenem and colistin-resistant Klebsiella pneumoniae ST512 clinical isolates in Israel: a cause for vigilance. Microb Drug Resist 2019; 25:63-71.
34. Oteo J, Perez-Vazquez M, Bautista V, et al; Spanish Antibiotic Resistance Surveillance Program Collaborating Group. The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones of Klebsiella pneumoniae ST11/KPC-2, ST101/KPC-2 and ST512/KPC-3. J Antimicrob Chemother 2016; 71:3392-9.
35. Villa L, Feudi C, Fortini D, et al. Diversity, virulence, and antimicrobial resistance of the KPC-producing Klebsiella pneumoniae ST307 clone. Microb Genom 2017; 3:e000110.
36. Can F, Menekse S, Ispir P, et al. Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection. J Antimicrob Chemother 2018; 73:1235-41.
37. Vubil D, Figueiredo R, Reis T, Canha C, Boaventura L, DA Silva GJ. Outbreak of KPC-3-producing ST15 and ST348 Klebsiella pneumoniae in a Portuguese hospital. Epidemiol Infect 2017; 145:595-9.
38. Tzouvelekis LS, Miriagou V, Kotsakis SD, et al. KPC-producing, multidrugresistant Klebsiella pneumoniae sequence type 258 as a typical opportunistic pathogen. Antimicrob Agents Chemother 2013; 57:5144-6.